US FDA Learns 'Lessons Of History,' Takes Opioid Fight To Gabapentinoids

 
• By Derrick Gingery
  
Clouds-Lightning-Storm_1200x675
The pharmaceutical alternative to a problematic pharmaceutical has problems. What are the odds?

More from US FDA

More from Agency Leadership